In what instance would taking both escitalopram (Selective Serotonin Reuptake Inhibitor - SSRI) and duloxetine (Serotonin-Norepinephrine Reuptake Inhibitor - SNRI) together be warranted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

There are no official guidelines to assist in answering this question. I will search for relevant research papers instead.

The FDA Drug Labels for escitalopram (PO), duloxetine (PO) do not address this question.

From the Research

Combination Therapy of Escitalopram and Duloxetine

There are no research papers to assist in answering this question regarding the specific instance in which taking both escitalopram (Selective Serotonin Reuptake Inhibitor - SSRI) and duloxetine (Serotonin-Norepinephrine Reuptake Inhibitor - SNRI) together would be warranted.

Efficacy and Safety of Escitalopram and Duloxetine

  • The studies 1, 2, 3, 4, 5 compared the efficacy and safety of escitalopram and duloxetine in the treatment of major depressive disorder.
  • Escitalopram was found to be at least as effective as duloxetine in the treatment of major depressive disorder, with a better tolerability profile 2, 3.
  • Duloxetine was found to be non-inferior to escitalopram in terms of onset of antidepressant action 4.
  • Both drugs demonstrated similar remission rates over the course of an 8-month study, with similar improvement on most efficacy measures 5.

Safety and Tolerability

  • Escitalopram was found to have a lower incidence of treatment-emergent adverse events compared to duloxetine 2.
  • Duloxetine was associated with a higher incidence of nausea, dry mouth, vomiting, yawning, and irritability compared to escitalopram 4.
  • Escitalopram was found to have a lower rate of discontinuation due to adverse events compared to duloxetine 2, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.